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Since 1963, reported malaria transmission in Haiti 
has been restricted to Plasmodium falciparum. However, 
screening of Haitian refugees in Jamaica in 2004, by micro-
scopic examination, identiﬁ  ed P. falciparum, P. vivax, and P. 
malariae. PCR conﬁ  rmed the P. malariae and P. falciparum 
but not P. vivax infections. DNA sequencing and rRNA gene 
sequences showed transmission of P. malariae. This report 
conﬁ  rms that P. malariae is still being transmitted in Haiti.
M
alaria remains an important disease in Latin America 
and the Caribbean, where 30.4% (264 million) of the 
869 million persons live in areas where ecologic conditions 
have been propitious for the transmission of malaria (1). En-
demic transmission of malaria in Jamaica was interrupted 
from 1960 through 1965, when the last cases (16 Plasmo-
dium malariae and 1 P. vivax) were reported (2). The island 
remains at risk for reintroduction of malaria because the pop-
ulation is immunologically naive and the vector, Anopheles 
albimanus, is endemic there (3). One possible route of re-
introduction is through infected persons from a malaria-en-
demic area such as Haiti. Transmission of endemic malaria 
in Haiti has been reported to be restricted to P. falciparum; 
the last cases of P. vivax were reported in 1983 and the last 
case of P. malariae in 1963 (1,2,4,5). P. falciparum, which 
was associated with Haitian immigrants, was the sole etio-
logic agent of reintroduced malaria, which caused recent an 
epidemic in Great Exuma Island, Bahamas (6).
The Study
From February through April 2004, 429 Haitian refu-
gees arrived by boat in Jamaica. Included in their health 
status screening was a microscopy examination for P. fal-
ciparum because malaria is well established in Haiti but is 
not endemic in Jamaica.
The refugees landed on Jamaica’s northeast shore, 
where they received chloroquine and primaquine and had 
blood was drawn for thick and thin blood ﬁ  lm preparation. 
The smears were then transported over land to the National 
Public Health Laboratory in Kingston for microscopic 
examination.
Of the samples from the 429 refugees, a subset of 274 
(which included posttreatment duplicates) was chosen by 
the Ministry of Health for inclusion in this aspect of the 
study. These samples included 30 P. falciparum isolates, 
13 P. vivax isolates, and 1 isolate of P. malariae based on 
microscopy examination; 31 samples were identiﬁ  ed only 
as Plasmodium sp. The lack of a deﬁ  nitive diagnosis may 
have been inﬂ  uenced by the quality of the smears made at 
ﬁ  rst contact with the patients and the fact that some smears 
were taken after initial treatment and contained only dying 
or dead parasites.
Samples from 94 patients (including some negative 
by microscopy examination as well as posttreatment du-
plicates) were sent to the Heath Protection Agency, Ma-
laria Reference Laboratory, London School of Hygiene and 
Tropical Medicine, for species conﬁ  rmation by PCR. DNA 
was extracted from 105 ﬁ  lter-paper blood spots and tested 
for DNA from P. falciparum. P. malaria, or P. vivax by 
using either the single-round PCR protocol of Padley et al. 
(7) or the more sensitive nested protocol of Snounou et al. 
(8). Of 15 isolates that were positive for P. malariae DNA 
by either or both PCR procedures, 7 also harbored P. fal-
ciparum DNA. Only 1 of the PCR-conﬁ  rmed P. malariae 
cases had been identiﬁ  ed as such by microscopy. Of the 
remainder, 2 samples contained P. vivax; 1 contained P. 
falciparum, and 4 were free of malaria parasites. Of the 105 
isolates tested, 57 were positive for P. falciparum DNA.
No cases of P. vivax were found with PCR. The ab-
sence of P. vivax was veriﬁ  ed by species-speciﬁ  c real-time 
PCR, as described by de Monbrison et al. (9)
Four P. malariae isolates were selected for DNA se-
quencing, and the rRNA gene sequences were ampliﬁ  ed by 
using a hybrid nested PCR approach. The ﬁ  rst-round PCR 
products were produced by using the ﬁ  rst stage of the nested 
PCR protocol; in the second round, the P. malariae–speciﬁ  c 
primers of Padley et al. (7), which lie wholly within the ﬁ  rst-
round PCR product, were used to amplify a ﬁ  nal product of 
425 bp. This was done because the much smaller nested PCR 
product produced by the protocol of Snounou et al. (8) (125 
bp) was not suitable for direct sequencing. Products were 
puriﬁ  ed by using the QIA Quick DNA extraction kit (QIA-
GEN, Crawley, UK), and directly sequenced on both strands 
by using the ABI BigDye sequencing kit (Applied Biosys-
tems, Warrington, UK) according to the manufacturer’s in-
structions, except that the reaction mix was diluted 8-fold 
before use. The forward and reverse PCR primers were used 
to prime the sequencing reaction. Reaction products were 
fractionated on an ABI capillary sequencer (Applied Biosys-
tems), and sequencing data were proofread with Chromas 
software (available from www.technylesium.com).
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The full sequence obtained from both strands of 1 rep-
resentative isolate was compared with 3 P. malariae rRNA 
gene sequences in GenBank, and to that of P. brasilianum 
that had been isolated from a monkey in French Guiana 
([10]; GenBank accession no. AF130735) by using the pro-
gram T-Coffee (http://ca.expasy.org/tools/#translate). The 
alignment produced is presented in the Figure. The Haitian 
sequence obtained matched very closely with all 4 P. ma-
lariae rRNA gene sequences in GenBank and with that of 
the indistinguishable simian parasite, P. brasilianum (10). 
Two single-nucleotide substitutions were observed in the 
sequence at positions 228 and 337, and each of these also 
occurred in at least 1 of the other 4 Haitian sequences we 
obtained (data not shown). Available sequence data for P. 
malariae are very scanty, and currently no well-established 
loci exist for examining genetic diversity in this species, 
apart from the small subunit rRNA genes (11).
Conclusions
Our results provide conclusive evidence that P. ma-
lariae is still being transmitted on the island of Hispaniola, 
which contains the countries of Haiti and the Dominican 
Republic. P. malariae and P. brasilianum have been re-
ported in both human and simian hosts in the continental 
South American states of Suriname, French Guiana, and 
Brazil (8,12,13), which are located on the northeastern 
coast of the continent, facing Hispaniola. Although a re-
cent introduction of P. malariae, due to movement of per-
sons, is possible, P. malariae has likely been present but 
unreported for a long period because it has been incorrectly 
diagnosed as P. vivax, as has occurred in Suriname (12). In-
deed, Garnham (14) described the ring forms of P. malari-
ae in blood ﬁ  lms as “rather like those of P. vivax,” although 
less amoeboid and with a more dense rim of cytoplasm.
The movement of P. malariae to Jamaica has impli-
cations for surveillance throughout the Caribbean and the 
southeastern United States. P. malariae infections can per-
sist without symptoms for long periods, and thus the ab-
sence of recent travel history to a malaria-endemic area is 
not a reliable criterion for ruling out a diagnosis of malaria 
caused by this species. Our study shows that molecular di-
agnostic methods can provide the sensitivity and discrimi-
nating power required to identify P. malariae in such infec-
tions.
Furthermore, Jamaica is especially at risk for rein-
troduction of malaria (as illustrated by the Great Exuma 
outbreak) because the population is immunologically naive 
and the competent vector, Anopheles albimanus, is endemic 
there. A reassessment of the risk for P. malariae infection 
in Haiti should be undertaken before control and elimina-
tion programs are implemented.
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Figure. Comparison of Plasmodium malariae (Pm) rRNA gene sequences (GenBank accession nos. AF487999, AF145336, AF488000) 
and P. brasilianum (Pb) sequences from a monkey from French Guiana (Fr Gu) (AF130735) with isolates from P. malariae of humans from 
Haiti (Haiti Pm). Plasmodium malariae in Haitian Refugees
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 6, June 2007  933 
Dr Lindo is a senior lecturer and consultant parasitologist in 
the Department of Microbiology, University of the West Indies, 
Kingston, Jamaica. His research interests include the epidemiol-
ogy of soil-transmitted nematode infections and emerging infec-
tious diseases.
References
    1.    Pan American Health Organization. Regional strategic plan for 
malaria in the Americas 2006–2010. [cited 2006 Oct 4]. Available 
from http://www.paho.org/English/AD/DPC/CD/mal-reg-strat-plan-
06.htm 
  2.   Pan American Health Organization. Status of malaria eradication 
in the Americas, 18th report. PAHO CSP 18/7 September–October 
1970. [cited 2007 Apr 11]. Available from http://hist.library.paho.
org/English/GOV/CSP/18_7.pdf 
    3.    Belkin JN, Heinemann SJ, Page WA. The culicidae of Jamaica 
(Mosquito Studies. XXI). Contrib Am Entomol Inst. 1970;6:1–319.
  4.   Kachur SP, Elda N, Vély JF, Benitez A, Bloland PB, Saint Jean Y, 
et al. Prevalence of malaria parasitemia and accuracy of micro-
scopic diagnosis in Haiti, October 1995. Rev Panam Salud Publica. 
1998;3:35–39. 
  5.   Bawden MP, Slaten DD, Malone JD. Falciparum malaria in a dis-
placed Haitian population. Trans R Soc Trop Med Hyg. 1995;89: 
600–3.
  6.   Centers for Disease Control and Prevention (CDC). Malaria—Great 
Exuma, Bahamas, May–June 2006. MMWR Morb Mortal Wkly 
Rep. 2006;55:1013–6. 
  7.   Padley D, Moody AH, Chiodini PL, Saldanha J. Use of a rapid, sin-
gle-round, multiplex PCR to detect malarial parasites and identify 
the species present. Ann Trop Med Parasitol. 2003;97:131–7.
  8.   Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Iden-
tiﬁ  cation of the four human malaria parasite species in ﬁ  eld samples 
by the polymerase chain reaction and detection of a high prevalence 
of mixed infections. Mol Biochem Parasitol. 1993;58:283–92.
  9.   de Monbrison F, Angei C, Staal A, Kaiser K, Picot S. Simultane-
ous identiﬁ  cation of the four human Plasmodium species and quan-
tiﬁ  cation of Plasmodium DNA load in human blood by real-time 
polymerase chain reaction. Trans R Soc Trop Med Hyg. 2003;97: 
387–90.
10.   Fandeur T, Volney B, Peneau C, de Thoisy B. Monkeys of the rain-
forest in French Guiana are natural reservoirs for P. brasilianum/P. 
malariae malaria. Parasitology. 2000;120:11–21.
11.   Liu Q, Zhu S, Mizuno S, Kimura M, Liu P, Isomura S, et al. Se-
quence variation in the small-subunit rRNA gene of Plasmodium 
malariae and prevalence of isolates with the variant sequence in 
Sichuan, China. J Clin Microbiol. 1998;36:3378–81.
12.    Scopel KK, Fontes CJ, Nunes AC, Horta MF, Braga EM. High 
prevalence of Plasmodium malariae infections in a Brazilian Ama-
zon endemic area (Apiacas-Mato Grosso State) as detected by poly-
merase chain reaction. Acta Trop. 2004;90:61–4.
13.   Voorham J, van Os N, van der Kaay HJ. Reappearance of Plas-
modium malariae in Suriname? Trans R Soc Trop Med Hyg. 
1993;87:243–4.
14.   Garnham PCC. Malaria parasites and other haemosporidia. Oxford 
(UK): Blackwell; 1966.
Address for correspondence: John F. Lindo, Department of Microbiology, 
The University of the West Indies, Kingston 7, Jamaica; email: john.
lindo@uwimona.edu.jm
Search 
past Issues